Overview

Alector, Inc. is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative diseases and rare diseases caused by immune dysfunction. The company's proprietary technology leverages immuno-neurology to treat diseases such as Alzheimer's and Parkinson's.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Alector, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.